Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Mirati Therapeutics, Inc.
About MRTX
Mirati Therapeutics, Inc. is a commercial-stage oncology company. The Company is developing novel therapeutics to address the genetic and immunological promoters of cancer. The Company's product KRAZATI is an oral targeted treatment option for adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC). Its MRTX1133 is an investigational, selective, and potent KRAS G12D inhibitor. Its MRTX1719 is an investigational synthetic lethal PRMT5 inhibitor designed to specifically target the PRMT5/ methylthioadensoine (MTA) complex. Its MRTX0902 is a potent, selective SOS1 inhibitor, designed to improve anti-tumor efficacy in combination with targeted mitogen-activated protein kinase (MAPK)-pathway inhibitors. Its Sitravatinib is an investigational spectrum-selective kinase inhibitor designed to potently inhibit receptor tyrosine kinases (RTKs) and enhance immune responses through the inhibition of immunosuppressive signaling.
Find out what a historical investment in Mirati Therapeutics, Inc. would be worth today using our MRTX stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy MRTX shares in Australia?
Buying MRTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Mirati Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MRTX
What is the ticker symbol of Mirati Therapeutics, Inc.?
The ticker symbol for Mirati Therapeutics, Inc. is MRTX.
How much is one share of MRTX?
One share of MRTX is valued at $59.00 as of 20 May 2026.
What is the market capitalisation of Mirati Therapeutics, Inc. MRTX?
As of 20 May 2026 Mirati Therapeutics, Inc. has a market cap of -.
What is the 52-week high for Mirati Therapeutics, Inc. stock?
The Mirati Therapeutics, Inc. 52-week high stock price is $NaN.
What is the 52-week low for Mirati Therapeutics, Inc. stock?
The Mirati Therapeutics, Inc. 52-week low stock price is $NaN.
Can I buy MRTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MRTX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MRTX on Stake
- Buy MRTX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MRTX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MRTX related stocks